Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium
- 31 May 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (2) , 483-488
- https://doi.org/10.1016/j.ygyno.2005.02.010
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Breast cancer prevention—clinical trials strategies involving aromatase inhibitorsThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- Cyclooxygenase‐2 expression in endometrial carcinomaCancer, 2002
- Enhanced Expression of Cyclooxygenase-2 in High Grade Human Transitional Cell Bladder CarcinomasThe American Journal of Pathology, 2000
- High Cyclooxygenase-2 Expression in Stage IB Cervical Cancer with Lymph Node Metastasis or Parametrial InvasionGynecologic Oncology, 2000
- Treatment of Human Endometrial Gland Epithelial Cells with Chorionic Gonadotropin/Luteinizing Hormone Increases the Expression of the Cyclooxygenase-2 GeneJournal of Clinical Endocrinology & Metabolism, 1999
- Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) geneEndocrinology, 1996
- Endometrial CarcinomaNew England Journal of Medicine, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Aspirin Use and Reduced Risk of Fatal Colon CancerNew England Journal of Medicine, 1991
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983